Affiliation:
1. Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science & Technology, Irbid, 22110, Jordan
2. Department of General Surgery & Urology, Faculty of Medicine, Jordan University of Science & Technology, Irbid, 22110, Jordan
Abstract
Aim: To analyze the direct medical costs of breast cancer (BC) patients in the north of Jordan. Patients: A cohort of BC patients treated during 2015 at King Abdullah University Hospital. Methods: A retrospective analysis of 119 patients, where all records including age, sex, treatment processes and costs were extracted from the patients’ profiles and examined. Results: The mean age of patients was 50.8 (±10.2) years. The total sample cost was Jordanian dinar 1,393,325 (US$1,963,560). The mean cost per patient from stage I to IV was Jordanian dinar 6696, 9183, 11,970 and 15,073, respectively. Medications were the most expensive resource used. Stage IV had the highest cost and largest number of patients. Conclusion: Direct medical costs associated with BC are considerable. Three-quarters of the cost were devoted to medications.
Subject
Radiology, Nuclear Medicine and imaging,Oncology
Reference38 articles.
1. Global cancer statistics, 2012
2. Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family Registry
3. Global cancer statistics, 2012
4. Economist intelligence unit. Breakaway: the global burden of cancer – challenges and opportunities (2009). www.livestrong.org/sites/default/files/what-we-do/reports/GlobalEconomicImpact.pdf
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献